Key result
Increasing shortest apposition length post-EVAR is linked to ~100% type 1a endoleak-free survival.
Why the study?
EVAR for AAA carries long-term complications such as endoleaks, so this study investigated the prognostic value of post-EVAR proximal seal length change for predicting type 1a endoleak.
Does the change in shortest apposition length (SAL) on post-EVAR CTA predict the development of type 1a endoleak and the need for secondary interventions in patients with infrarenal AAA?
Observational (n=310)
Yes
Does the change in shortest apposition length (SAL) on post-EVAR CTA predict the development of type 1a endoleak and the need for secondary interventions in patients with infrarenal AAA?
Absolute Event Rate: 100% vs 81.6%
p-value: p=<0.001
An increasing shortest apposition length (SAL) after EVAR is a strong indicator of durable success, predicting freedom from type 1a endoleak and related secondary interventions at 5 years.
Increasing shortest apposition length was associated with fewer type 1a endoleaks post-EVAR; leaves open whether measurement should refine surveillance protocols.
OBJECTIVE: Endovascular aortic repair (EVAR) for an aneurysm of the abdominal aorta (AAA) is associated with long-term complications, such as endoleaks, resulting in a significant re-intervention rate. This study investigates the prognostic value of (change of) proximal seal length on post-EVAR computed tomography angiography (CTA) for predicting type 1a endoleak. It further proposes a risk-stratified imaging follow-up algorithm. DESIGN: Multicentre, retrospective, observational study of consecutive patients who underwent elective EVAR for infrarenal AAA between 2015 and 2018 at 3 high-volume hospitals in the Netherlands. MATERIALS AND METHODS: Aorta morphology and endograft position analysis was performed. Shortest apposition length (SAL) was measured on the first post-EVAR CTA and, if available, on the last CTA. Change of SAL through time was categorized as increasing, stable, or decreasing and correlated with type 1a endoleak and secondary interventions for endoleak. Kaplan-Meier analysis was used to calculate type 1a endoleak free and re-intervention-free survival. RESULTS: Three hundred ten AAA patients with a median follow-up of 51 (Q1, 17; Q3, 71) months were included. A median SAL of 22.8 mm (Q1, 15.9; Q1, 30.4) was measured on the first post-EVAR CTA. In 168 of 310 patients (54%), a second post-EVAR CTA was available, in which 71 (42%) showed increasing SAL over time. No type 1a endoleak developed in the increasing SAL group, whereas 1 of 43 (2%) in the stable group and 10 of 54 (19%) in the decreasing group developed type 1a endoleak. Five years post-EVAR, type 1a endoleak-free survival was 100% in the increasing SAL group versus 97.1% in the stable SAL group (p=0.195), and 81.6% in the decreasing SAL group (p<0.001). The re-intervention for all types of endoleak-free survival was 100% in the increasing SAL group versus 84.6% in the stable SAL group (p<0.001), and 60.7% (p<0.001) in the decreasing SAL group. CONCLUSION: Increasing SAL after EVAR for infrarenal degenerative AAA is an indicator of durable success without type 1a endoleak and endoleak-associated secondary intervention within 5 years. Decreasing SAL is associated with development of type 1a endoleak after EVAR. Evaluation of (change of) the proximal seal could be a valuable part of follow-up after EVAR.Clinical ImpactEvaluation of proximal seal length after endovascular aortic repair offers valuable prognostic information regarding the risk of type 1a endoleak. Implementation could refine current follow-up algorithms to better stratify patients who have a substantial risk of type Ia endoleak from patients who may benefit from limited image surveillance.
No takes yet. Share an insight, caveat, or question.
Hendricks et al. (2025) conducted an observational in Infrarenal abdominal aortic aneurysm (n=310). Increasing shortest apposition length (SAL) vs. Decreasing shortest apposition length (SAL) was evaluated on Type 1a endoleak-free survival at 5 years (p=<0.001). Increasing shortest apposition length after EVAR was associated with 100% type 1a endoleak-free survival at 5 years, compared to 81.6% for decreasing length (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: